Chronic Wound Infections: New Drug Combo Speeds Healing
Summary of the Article: Novel Approach to Treating Diabetic Foot Ulcers
This article details research led by Dr. Spero at the University of Oregon, focusing on a new strategy to combat chronic bacterial infections in diabetic foot ulcers. Here’s a breakdown of the key points:
* The Problem: Diabetic foot ulcers are common (affecting 1 in 4 people with Type 2 diabetes) and often become infected.These infections are tough to treat due to limited oxygen in the wound, wich promotes antibiotic resistance and slow bacterial growth. Severe cases can lead to amputation (1 in 5 ulcers).
* The Mechanism: Bacteria in these oxygen-deprived wounds switch to using nitrate for energy (nitrate respiration), slowing their growth but allowing them to survive and resist antibiotics. Standard antibiotic testing is done in oxygen-rich environments and targets fast-growing bacteria, making them ineffective against these slow-growing, nitrate-respiring bacteria.
* The Solution: Dr. Spero’s research shows that combining antibiotics with a small molecule called chlorate significantly increases the antibiotics’ effectiveness. Chlorate “stresses” the bacterial cells, making them more vulnerable to the antibiotics.
* The Research:
* Previous studies (at Caltech) showed chlorate boosted antibiotic effectiveness in cell cultures and diabetic mouse models.
* A $1.84 million NIH grant is funding continued research at the UO.
* Recent findings demonstrate chlorate enhances the effectiveness of various antibiotics against P. aeruginosa (a common bacteria in these ulcers) and allows for significantly lower antibiotic dosages (e.g., 1% of the standard dose of ceftazidime).
* The Benefit: Lowering antibiotic dosage and treatment duration reduces the risk of harmful side effects like gut microbiome disruption and toxicity.
* Next Steps: the research is currently based on lab tests and needs to be translated into clinical trials to determine its effectiveness in humans.
In essence, the research offers a promising new approach to treating stubborn infections in diabetic foot ulcers by making existing antibiotics more potent and reducing the need for high doses and prolonged treatment.